| Name | Title | Contact Details |
|---|
Intersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients.
scanlan international inc is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Evergreen Research Corporation has performed contract product development with an emphasis on medical devices since 1988. Evergreen Research offers a complete range of development services from product definition and feasibility studies through detailed design to pilot-run and low-volume production.Their experience and resourceful staff, seasoned program management, and knowledge of regulations ensure customer satisfaction and compliance with regulatory requirements. Evergreen Research, Inc. also known as ERI, has developed advanced electromechanical and software-based products providing a complete range of development services, such as product requirements definition, project planning, risk management, comprehensive design expertise (electrical, mechanical, software and industrial), design documentation, verification and validation, clinical studies, regulatory approvals, production quality planning and much more. Evergreen Research Advantages include highly skilled electrical, mechanical, and software engineers, on-site regulatory and quality expertise, manufacturing capability to build prototypes and marketed products such as Therapeutic Devices, Diagnostic Systems, Medical Software and Medical Imaging products.
Blackrock Neurotech builds implantable brain technology that changes lives. Our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer`s, Parkinson`s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders.
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA qualification for air cargo screening, the Company's QS-B220 has also received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act), and the GSN 2013 Homeland Security Award for "Best Explosives Detection Solution".